Upon these regulatory wins, Thermogard now offers the versatility of core and surface-based temperature management treatment options. The single, streamlined platform has solutions for personalized patient care with precise temperature control and intelligent analytics.
“Thermogard with both catheter-based and pad options supports our mission to improve patient outcomes and help save lives,” Zoll Circulation President Christopher Barnabas said in a news release. “Zoll’s Thermogard platform is now the only all-in-one temperature management technology. This novel, one-of-a-kind solution delivers high-quality patient care while supporting hospitals’ evolving treatment protocols and decreasing the workload for nursing staff.”
Thermogard uses Zoll’s patented variety of catheters, doubling as a standard central venous catheter to deliver precise temperature management. Data on the system gives insights to support rapid patient assessment to analyze in-depth, post-case patient data to support quality improvement initiatives.
